Eli Lilly Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
1. Eli Lilly's Q4 earnings expected at $5.08/share, significant growth from last year. 2. Projected revenue for Q4 is $13.43 billion, up from $9.35 billion. 3. 2024 revenue forecast is $45 billion, showing 32% growth year-over-year. 4. Wells Fargo downgraded LLY's price target from $1,000 to $970. 5. Analysts maintain positive outlook with several Buy and Overweight ratings.